Senior Clinical Trial ManagerBoston Scientific, United States
Disclosure information not submitted.
220 - Y90 Radioembolization Planning for Recurrent Glioblastoma: Angiographic Analysis
Tuesday, April 14, 20263:27 PM - 3:36 PM ET